These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9547438)
21. Disappointing recent cholesterol-lowering drug trials: is it not time for a full reappraisal of the cholesterol theory? de Lorgeril M World Rev Nutr Diet; 2009; 100():80-89. PubMed ID: 19696530 [No Abstract] [Full Text] [Related]
22. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Ballantyne CM; Olsson AG; Cook TJ; Mercuri MF; Pedersen TR; Kjekshus J Circulation; 2001 Dec; 104(25):3046-51. PubMed ID: 11748098 [TBL] [Abstract][Full Text] [Related]
23. [One more (conclusive?) confirmation of ineffectiveness of antioxidant vitamins for prevention of coronary heart disease]. Gratsiansky NA Kardiologiia; 2002; 42(2):85-6. PubMed ID: 12494214 [No Abstract] [Full Text] [Related]
24. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease. Haffner SM Diabetes Care; 1997 Apr; 20(4):469-71. PubMed ID: 9096961 [No Abstract] [Full Text] [Related]
35. [Are there differences in various statins?]. Otto C; Schwandt P Internist (Berl); 1998 Sep; 39(9):987-93. PubMed ID: 9788127 [No Abstract] [Full Text] [Related]
36. [Dual lipid control without anti-atherosclerosis effect]. Einecke D MMW Fortschr Med; 2008 Apr; 150(16):18, 20. PubMed ID: 18557109 [No Abstract] [Full Text] [Related]
37. Do statin drugs lower the risk of stroke? Sabharwal M; Por CP; Evans MF Can Fam Physician; 1998 May; 44():1003-4. PubMed ID: 9612584 [No Abstract] [Full Text] [Related]
38. Lipid-lowering therapy in patients with coronary artery disease: sex or age bias? Sgadari A; Incalzi RA; Onder G; Pedone C; Gambassi G Arch Intern Med; 2000 Sep; 160(17):2684-5. PubMed ID: 10999995 [No Abstract] [Full Text] [Related]
39. Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives. McKenna CJ; Sugrue DD Ir Med J; 1995; 88(6):191. PubMed ID: 8575912 [No Abstract] [Full Text] [Related]
40. [The IMPROVE-IT trial showed no favorable effects on well-defined and clinically relevant endpoints]. Mascitelli L; Goldstein MR G Ital Cardiol (Rome); 2015 Dec; 16(12):739. PubMed ID: 26667950 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]